Innovative Gene-Editing 'Molecular Scissors' Offer New Hope for Chronic Hepatitis B Treatment
Advances in gene-editing technology using TALENs show promise in targeting and eliminating the stubborn cccDNA of hepatitis B, offering hope for more effective treatments and potential cures for millions affected worldwide.
Recent advancements in gene-editing technology have introduced a promising approach to combating chronic hepatitis B (HBV), a persistent viral infection that affects millions worldwide, especially in regions like South Africa. Researchers led by Dr. Tiffany Smith of the Antiviral Gene Therapy Research Unit have developed a novel method utilizing TALENs (transcription activator-like effector nucleases) to precisely target and disable the virus's genetic material.
Unlike other gene-editing tools such as CRISPR, TALENs do not rely on guide RNAs, making them effective even in complex DNA structures. The team's breakthrough centers on targeting covalently closed circular DNA (cccDNA), the 'mini chromosome' that HBV uses to hide within liver cells and sustain infection. Current treatments can suppress virus activity but cannot eradicate cccDNA, leading to potential relapse after therapy cessation.
Preclinical studies have shown significant results: in cultured human liver cells, the treatment reduced hepatitis B markers by 80%, and in infected mice, a single dose caused a 99% reduction in circulating viral DNA. Importantly, the therapy was well tolerated, with only mild, temporary inflammation observed.
This innovation could pave the way for more effective, possibly curative, treatments for HBV. The team is combining TALENs with mRNA delivery via lipid nanoparticles, a platform previously successful in vaccine development, to enhance precision and safety. While further research is needed to confirm these findings in humans, this development marks a significant step toward a functional cure for hepatitis B.
Hepatitis B remains a major health concern, especially in resource-limited settings where lifelong antiviral therapy is burdensome. The potential to directly eliminate the virus's genetic blueprint offers hope for a future where hepatitis B can be effectively controlled or eradicated.
Source: https://medicalxpress.com/news/2025-08-generation-molecular-scissors-chronic-hepatitis.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative AI Enhances Women's Heart Risk Assessment Using Routine Mammograms
A new AI-driven method uses routine mammogram images and age data to accurately predict women's cardiovascular disease risk, offering a cost-effective, dual-purpose screening tool.
Racial Disparities in Postoperative Minor Complications After Bariatric Surgery
A new study reveals that Black patients face higher rates of minor complications after bariatric surgery compared to White patients, highlighting ongoing racial disparities in postoperative health outcomes.
Reevaluating Low-Grade Prostate Cancers: Higher Risks Than Biopsy Results Indicate
New research indicates that some low-grade prostate cancers may pose higher risks than biopsy results suggest, urging a more comprehensive approach to diagnosis and treatment planning.
The Link Between Poverty, Loneliness, and Physical and Emotional Symptoms
New research links poverty and loneliness to increased pain, fatigue, and low mood, highlighting the importance of social support in mitigating health disparities across socioeconomic groups.